Target intelligence / Profile preview

Protein interacting with C kinase 1 (PICK1)

Target
PICK1
Molecular classification
Adaptor protein, Scaffold protein, PDZ domain protein, BAR domain protein, Other
01

Overview

Protein interacting with C kinase 1 (PICK1) is a cytosolic adaptor and scaffold protein distinguished by its PDZ and BAR domains, best known for regulating the trafficking and subcellular localization of diverse membrane proteins, especially the AMPA-type glutamate receptors, at neuronal synapses[1][3][5][7]. PICK1 interacts with protein kinase C alpha (PRKCA), and its activity is critical for synaptic plasticity, learning, and memory, functioning via the clustering and internalization of receptors[1][3]. It has also been implicated in actin cytoskeleton organization and the development of certain forms of male infertility[1]. Recent research has positioned PICK1 as a potential therapeutic target, especially for neuropsychiatric and neurodegenerative disorders, through development of selective inhibitors that disrupt PICK1–GluA2 interactions and associated synaptic dysfunction[5].

Other names
PRKCABPPRKCA-binding proteinProtein kinase C-alpha-binding proteindJ1039K5MGC15204protein interacting with PRKCA 1PICK
02

Mechanism of action

Disruption of PICK1–GluA2/AMPA receptor PDZ domain interaction; Modulation of receptor trafficking/synaptic localization[5]

03

Biological functions

Receptor trafficking (notably AMPA receptors)Synaptic plasticityRegulation of membrane protein localizationActin cytoskeleton organizationSignal transduction
04

Disease associations

Neurodegenerative diseaseMale infertility (globozoospermia, spermatogenic failure)Synaptic dysfunction/cognitive disordersOther
05

Safety considerations

Synaptic plasticity alteration may affect cognition, memory, and neuronal survivalDisruption may influence broader glutamatergic signaling, raising risk of CNS side effects[5]
06

Interacting drugs

PICK1 PDZ domain small molecule inhibitors (experimental, not clinically approved)[5]
07

Biomarkers

None established for patient selection or clinical monitoring (as of latest data)

Beyond the preview

Go deeper on Protein interacting with C kinase 1 (PICK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein interacting with C kinase 1 (PICK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call